Profile data is unavailable for this security.
About the company
Jilin Province Huinan Changlong Bio-pharmacy Company Limited is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products. Its products are mainly sold under the brand names of Changlong and Qing Tong. Its primary products include tablets, capsules, bulk drug, membrane, pills, bulk drug, powder for injection, lyophilized powder for injection, small volume parenteral solutions, sterile bulk drug and solution. The Company is also engaged in the trading of biochemical medicine through its subsidiaries. Its principal subsidiaries include Jilin Province Huinan Changlong Pharmacy Trading Company Limited and Jilin Province Medicinal Plants Trading Company Limited.
- Revenue in HKD (TTM)901.25m
- Net income in HKD184.38m
- Incorporated1996
- Employees678.00
- LocationJilin Province Huinan Changlong Bio-pharmacy Co LtdNo. 31 Beishan StreetChaoyang Town, Huinan CountyTONGHUA 135100ChinaCHN
- Phone+86 4 358218333
- Fax+86 4 358210005
- Websitehttp://www.jlchanglong.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3D Medicines Inc | 525.09m | -483.09m | 521.58m | 193.00 | -- | 0.5727 | -- | 0.9933 | -2.05 | -2.05 | 2.20 | 3.53 | 0.3746 | 4.94 | 5.79 | 2,651,946.00 | -37.27 | -- | -50.88 | -- | 91.97 | -- | -99.50 | -- | 2.56 | -- | 0.2517 | -- | 11.91 | -- | 48.78 | -- | -- | -- |
| Fusen Pharmaceutical Co Ltd | 457.06m | -96.33m | 665.37m | 1.14k | -- | 1.21 | -- | 1.46 | -0.1292 | -0.1292 | 0.6136 | 0.7455 | 0.3212 | 1.68 | 5.01 | 398,137.50 | -6.77 | 0.9678 | -13.96 | 1.74 | 53.18 | 51.95 | -21.08 | 2.59 | 0.526 | -2.10 | 0.4031 | 27.95 | 15.02 | 4.13 | -4.83 | -- | 0.2124 | -- |
| Lee's Pharmaceutical Holdings Ltd | 1.20bn | 63.06m | 724.27m | 993.00 | 11.49 | 0.4227 | 3.69 | 0.604 | 0.1071 | 0.1071 | 2.04 | 2.91 | 0.4403 | 2.11 | 9.70 | 1,134,410.00 | 1.98 | 13.33 | 2.52 | 17.76 | 51.49 | 61.92 | 4.50 | 36.20 | 0.7425 | 6.58 | 0.132 | 3.59 | -14.61 | -1.53 | -67.44 | -47.49 | -12.19 | -31.34 |
| Zhaoke Ophthalmology Ltd | 61.46m | -243.91m | 742.75m | 297.00 | -- | 0.3401 | -- | 12.09 | -0.4478 | -0.4478 | 0.1128 | 4.00 | 0.0233 | 1.25 | 16.09 | 196,357.80 | -9.23 | -- | -10.51 | -- | 82.03 | -- | -396.86 | -- | 5.48 | -24.02 | 0.1114 | -- | -- | -- | 5.47 | -- | -- | -- |
| Pak Fah Yeow International Ltd | 265.21m | 96.45m | 760.40m | 101.00 | 7.89 | 1.01 | 7.33 | 2.87 | 0.3094 | 0.3094 | 0.8507 | 2.41 | 0.2869 | 2.84 | 23.53 | 2,600,118.00 | 10.44 | 3.99 | 11.32 | 4.18 | 87.05 | 80.79 | 36.37 | 21.27 | 4.22 | 5.26 | 0.0055 | 100.68 | 76.06 | 12.94 | 250.66 | 23.02 | 18.83 | -8.06 |
| Zhongzhi Pharmaceutical Holdings Ltd | 2.20bn | 119.57m | 777.24m | 2.74k | 6.37 | 0.6538 | 3.36 | 0.354 | 0.1412 | 0.1412 | 2.59 | 1.38 | 1.09 | 2.68 | 7.39 | 830,705.70 | 5.99 | 7.69 | 9.17 | 11.75 | 57.55 | 60.44 | 5.49 | 6.73 | 0.9033 | 213.59 | 0.1516 | 42.46 | 12.26 | 12.41 | 53.00 | 13.86 | 17.65 | -- |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 901.25m | 184.38m | 789.95m | 678.00 | 4.28 | 0.4641 | 6.38 | 0.8765 | 0.3291 | 0.3291 | 1.61 | 3.04 | 0.3574 | 2.10 | 2.94 | 1,062,796.00 | 7.31 | 7.67 | 10.25 | 10.48 | 75.46 | 78.79 | 20.46 | 20.68 | 1.62 | -- | 0.0502 | 7.22 | -0.0049 | 5.38 | -23.43 | -1.67 | -1.14 | -- |
| Hbm Holdings Ltd | 562.02m | 165.78m | 979.73m | 158.00 | 5.68 | 0.9833 | 5.00 | 1.74 | 0.2253 | 0.2253 | 0.7623 | 1.30 | 0.3258 | 3.96 | 16.67 | 3,175,272.00 | 9.59 | -54.61 | 13.25 | -66.04 | 95.57 | 97.81 | 29.42 | -400.28 | 3.44 | 8.14 | 0.3502 | -- | 120.13 | 127.06 | 116.61 | -- | -12.62 | -- |
| Jbm (Healthcare) Ltd | 648.42m | 130.46m | 1.16bn | 279.00 | 9.53 | 1.21 | 6.31 | 1.79 | 0.1479 | 0.1479 | 0.7338 | 1.17 | 0.4645 | 4.25 | 5.98 | 2,324,068.00 | 9.83 | 4.38 | 12.04 | 5.52 | 52.14 | 46.47 | 21.16 | 12.69 | 1.25 | 89.68 | 0.1155 | 32.98 | 24.62 | 16.09 | 128.51 | 19.99 | 2.26 | -- |
Data as of Nov 22 2024. Currency figures normalised to Jilin Province Huinan Changlong Bio-pharmacy Co Ltd's reporting currency: Hong Kong Dollar HKD
0.02%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FIL Investments Internationalas of 30 Jun 2024 | 32.00k | 0.02% |
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
